Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

163 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

NCT00774358

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • The Texas Children's Hospital Houston, Texas, United States
View Trial Details
Completed

Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study

NCT01287689

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +5 more
Locations
  • Klinik für Neurologie, St. Josefs-Hospital der Ruhr-Univ. Bochum, Germany
  • Praxis für Hämatologie und Internistische Onkologie Cologne, Germany
  • Institute for Clinical Pharmacology Dresden, Germany
  • Klinik für Neurologie, Medizinische Hochschule Hanover, Germany
View Trial Details
Completed

High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam)

NCT01313507

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • University of California Irvine Irvine, California, United States
  • Immunoe Research Center Centennial, Colorado, United States
  • Rush Universtity Medical Center Chicago, Illinois, United States
  • Cardinal Glennon Children's Hospital St Louis, Missouri, United States
View Trial Details
Completed

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

NCT01963143

Conditions
Blood Protein Disorders, Bruton type agammaglobulinemia, Common Variable Immunodeficiency, +12 more
Locations
  • Arizona Allergy Associates Chandler, Arizona, United States
  • Miller Children's Hospital Long Beach, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 17 locations
View Trial Details
Completed

A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

NCT01012323

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +2 more
Locations
  • Sudir Gupta, MD Irvine, California, United States
  • Isaac Melamed, MD Centennial, Colorado, United States
  • James Moy, MD Chicago, Illinois, United States
  • William Smits, MD Fort Wayne, Indiana, United States
View Trial Details
Completed

Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects

NCT00634569

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Protein Disorders, +18 more
Locations
  • University of South Florida St. Petersburg, Florida, United States
  • Family Allergy & Asthma Center, PC Atlanta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • The Allergy and Asthma Center Fort Wayne, Indiana, United States
View Trial Details
Completed

Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

NCT01814800

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • IMMUNOe Health Centers Cenntennial, Colorado, United States
  • Allergy Associates of the Palm Beaches, P.A. North Palm Beach, Florida, United States
  • Family Allergy Center, PC Atlanta, Georgia, United States
  • The South Bend Clinic, LLP South Bend, Indiana, United States
View Trial Details

Related conditions